|
TRRAP expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.809300E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.143500E-03 |
| Normal-vs-Stage2 |
6.955800E-02 |
| Normal-vs-Stage3 |
1.208790E-04 |
| Normal-vs-Stage4 |
2.159500E-04 |
| Stage1-vs-Stage2 |
7.157000E-01 |
| Stage1-vs-Stage3 |
9.702100E-02 |
| Stage1-vs-Stage4 |
9.978000E-02 |
| Stage2-vs-Stage3 |
1.472230E-01 |
| Stage2-vs-Stage4 |
1.692850E-01 |
| Stage3-vs-Stage4 |
9.459200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.602600E-04 |
| Normal-vs-AfricanAmerican |
1.613640E-01 |
| Normal-vs-Asian |
1.495770E-02 |
| Caucasian-vs-AfricanAmerican |
4.566800E-01 |
| Caucasian-vs-Asian |
8.674400E-01 |
| AfricanAmerican-vs-Asian |
5.901400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.58779999999537E-05 |
| Normal-vs-Female |
3.697000E-03 |
| Male-vs-Female |
8.777600E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.395910E-02 |
| Normal-vs-Age(41-60Yrs) |
2.824100E-03 |
| Normal-vs-Age(61-80Yrs) |
4.24119999999917E-05 |
| Normal-vs-Age(81-100Yrs) |
1.098230E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.302400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.731700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.014000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.045200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.184800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.855200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.297100E-03 |
| Classical-VS-Follicular |
5.008500E-04 |
| Classical-VS-Other |
1.336230E-01 |
| Classical-VS-Normal |
2.965600E-02 |
| Tall-VS-Follicular |
8.846400E-01 |
| Tall-VS-Other |
7.597000E-01 |
| Tall-VS-Normal |
2.208500E-04 |
| Follicular-VS-Other |
7.500400E-01 |
| Follicular-VS-Normal |
3.52030000000392E-05 |
| Other-VS-Normal |
2.036500E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.857160E-03 |
| Normal-vs-N1 |
2.624600E-04 |
| N0-vs-N1 |
2.928000E-01 |
|
|
